Protomex will provide an innovative solution for early diagnosis and improved treatment of neonatal sepsis (description: infants with severe blood infections). It is the industry’s first handheld device that will empower physicians to more accurately and rapidly treat life threatening neonatal infections while dramatically limiting the side effects and costs associated with blood transfusions and overtreatment.